News & Updates
Filter by Specialty:
GLP-1 RA benefit may branch out into obesity-related cancers
Another feather may have been added in the cap of glucagon-like protein-1 receptor agonists (GLP-1 RAs) – the class of type 2 diabetes (T2D) drugs that has become a blockbuster recently due to their remarkable weight loss benefit – as evidence of their potential to reduce the risk of obesity-associated cancers (OACs) comes to light.
GLP-1 RA benefit may branch out into obesity-related cancers
17 Sep 2024
Cruciferous vegetables help avert recurrence in NMIBC patients on BCG
Higher consumption of raw cruciferous vegetables appears to reduce the risk of recurrence in nonmuscle-invasive bladder cancer (NMIBC) patients treated with induction bacillus Calmette-Guérin (BCG), suggests a study.
Cruciferous vegetables help avert recurrence in NMIBC patients on BCG
16 Sep 2024
Enzalutamide edges out abiraterone in mCRPC
In the treatment of patients with metastatic castration-resistant prostate cancer (mCRPC), the use of enzalutamide yields small improvements in outcomes when compared with abiraterone acetate, according to a retrospective study.
Enzalutamide edges out abiraterone in mCRPC
15 Sep 2024
Conservative excisional margin for small MIS tied to low recurrence
For small-sized melanoma in situ (MIS; <10 mm) on low-risk body sites, wide local excision (WLE) using a 5-mm margin was associated with a low rate of recurrence, a retrospective case series study has shown.